ViaCyte

CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
BioSpace
Mon, 03/13/23 - 10:21 am
ViaCyte
CRISPR Therapeutics
Genprex
diabetes
gene therapy
Vertex Pharma (VRTX) to Acquire ViaCyte for $320 Million
Street Insider
Mon, 07/11/22 - 10:42 am
Vertex Pharmaceuticals
M&A
ViaCyte
type 1 diabetes
stem cells
ViaCyte's Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies
Drugs.com
Thu, 12/2/21 - 10:55 pm
ViaCyte
type 1 diabetes
clinical trials
stem cells
CRISPR, ViaCyte beat Vertex to the clinic with diabetes cell therapy that evades the immune system
Endpoints
Tue, 11/16/21 - 10:34 am
CRISPR Therapeutics
ViaCyte
Vertex Pharmaceuticals
type 1 diabetes
cell therapy
gene editing
ViaCyte reports positive cell replacement result for diabetes
Biopharma Reporter
Tue, 06/29/21 - 10:50 am
ViaCyte
islet cell replacement
type 1 diabetes
diabetes
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments
Xconomy
Tue, 05/26/20 - 11:52 am
ViaCyte
diabetes
gene editing
stem cells
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
Xconomy
Thu, 11/29/18 - 12:15 am
ViaCyte
stem cells
diabetes
IPOs
clinical trials
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Xconomy
Mon, 09/17/18 - 03:18 pm
ViaCyte
stem cells
diabetes
CRISPR Therapeutics
J&J, Viacyte team up on a potential stem cell therapy 'cure' for type 1 diabetes
BioPharma Dive
Wed, 02/10/16 - 03:18 pm
JNJ
ViaCyte
stem cells
type 1 diabetes
J&J pours another $20M into ViaCyte and sizes up its diabetes treatment
Fierce Biotech
Fri, 08/22/14 - 12:17 pm
JNJ
ViaCyte
diabetes